How to Store Antibodies for Western Blotting: Maintaining Specificity and Activity

Antibody storage for western blotting is the systematic process of preserving primary and secondary antibodies under conditions that maintain their binding specificity, affinity, and structural integrity from receipt through repeated use. Proper storage is essential because antibodies are labile proteins susceptible to denaturation, aggregation, proteolysis, and microbial contamination—all of which degrade performance and compromise experimental reproducibility. This article provides evidence-based guidance on storage temperature, aliquotting strategies, buffer additives, and handling practices to maximize antibody longevity and activity, specifically for western blotting applications.

At a Glance

Scientific Principles of Antibody Stability

Antibodies are immunoglobulin proteins composed of heavy and light chains held together by disulfide bonds and non-covalent interactions. Their three-dimensional structure, particularly the complementarity-determining regions (CDRs) that confer antigen specificity, is maintained by a delicate balance of hydrophobic interactions, hydrogen bonds, and electrostatic forces. Storage conditions that disrupt these forces lead to irreversible denaturation and loss of binding activity.

The primary degradation pathways for stored antibodies include:

Aggregation: Antibodies can form soluble or insoluble aggregates through hydrophobic interactions, especially when subjected to freeze-thaw cycles or high concentrations. Aggregates reduce effective antibody concentration and can cause high background in western blots due to non-specific binding.

Proteolysis: Trace amounts of proteases, either co-purified or introduced during handling, can cleave antibody molecules. This is particularly problematic for polyclonal antibodies, which may contain heterogeneous populations of immunoglobulins.

Deamidation and oxidation: Asparagine and glutamine residues can undergo non-enzymatic deamidation over time, altering charge and potentially affecting binding affinity. Methionine and tryptophan residues are susceptible to oxidation, especially in the presence of light or reactive oxygen species.

Microbial contamination: Bacteria and fungi can grow in antibody solutions stored at 4°C, producing proteases and other metabolites that degrade antibodies. This is a particular concern for antibodies stored without preservatives.

The evidence from studies using western blotting to monitor antibody responses underscores the importance of antibody integrity. In a longitudinal study of brucellosis patients, researchers used western blotting to track antigen-specific antibody responses over extended periods, with BP26-specific antibodies remaining detectable up to 395 days post-infection [1]. This work demonstrates that antibodies can retain binding activity for extended periods when properly stored, but also highlights that antibody stability is critical for reliable detection in diagnostic and research settings.

Storage Temperature: Balancing Stability and Accessibility

Long-Term Storage at -20°C

For antibodies that will not be used within two weeks, storage at -20°C is the standard recommendation. At this temperature, molecular motion is significantly reduced, slowing both enzymatic degradation and chemical modification reactions. However, freezing introduces its own challenges.

When water freezes, solutes become concentrated in the remaining liquid phase, creating conditions of high ionic strength and extreme pH shifts that can denature proteins. Ice crystal formation can also physically damage protein structure. To mitigate these effects, antibodies should be stored in a buffer containing a cryoprotectant, typically 50% glycerol (v/v). Glycerol lowers the freezing point of the solution, keeping it in a liquid or semi-liquid state at -20°C and preventing ice crystal formation.

Important consideration: Antibodies stored in 50% glycerol at -20°C remain liquid and can be pipetted directly without thawing. This eliminates the need for freeze-thaw cycles during routine use. However, the glycerol concentration must be maintained; if the solution is diluted below approximately 40% glycerol, freezing may occur.

Short-Term Storage at 4°C

For antibodies used frequently (within 1–2 weeks), storage at 4°C is acceptable and often preferred to avoid the handling steps associated with frozen storage. At 4°C, enzymatic activity is slowed but not eliminated, and chemical modifications continue at reduced rates. The primary risk at 4°C is microbial contamination, which is addressed by including a preservative such as sodium azide.

Decision point: The choice between 4°C and -20°C storage depends on usage frequency and antibody stability. Some antibodies, particularly those conjugated to enzymes or fluorophores, may be more stable at 4°C than at -20°C due to the sensitivity of the conjugate to freeze-thaw damage. Always consult the manufacturer's recommendations, which are based on stability testing of that specific product.

Storage at -80°C

For extremely long-term storage (years) or for antibodies that are particularly unstable, -80°C storage may be used. At this temperature, all molecular motion is essentially halted, and chemical reactions proceed at negligible rates. However, -80°C storage requires careful handling to avoid freeze-thaw damage. Antibodies should be aliquoted into single-use volumes before freezing, and thawing should be performed rapidly (e.g., by placing the tube in a 37°C water bath for 1–2 minutes) to minimize ice crystal formation during the thawing process.

Note: Not all antibodies require -80°C storage. Most commercial antibodies are formulated for stability at -20°C and will maintain activity for years at this temperature. The -80°C option is typically reserved for antibodies that show instability at -20°C or for archival storage of irreplaceable reagents.

Aliquotting: Preventing Freeze-Thaw Damage

Repeated freeze-thaw cycles are one of the most common causes of antibody activity loss. Each cycle exposes the antibody to the stresses of ice crystal formation, solute concentration, and temperature changes. Studies have shown that even a single freeze-thaw cycle can reduce antibody binding activity by 10–30%, and three or more cycles can lead to substantial loss.

The solution is to aliquot antibodies into single-use volumes before initial freezing. The appropriate aliquot volume depends on the typical amount of antibody used per experiment. For western blotting, primary antibodies are typically used at dilutions of 1:500 to 1:10,000, meaning that 1–10 µL of stock antibody is used per blot. A practical aliquot volume is 10–50 µL, which provides enough antibody for 5–50 experiments while minimizing waste.

Practical guidance:

• Use sterile, low-protein-binding microcentrifuge tubes (polypropylene)
• Label each aliquot with antibody name, concentration, date, and lot number
• For antibodies stored at -20°C in 50% glycerol, aliquots can be removed and returned to storage without thawing, as the solution remains liquid
• For antibodies stored at -80°C, thaw each aliquot only once and discard any unused portion

Buffer Additives: Enhancing Stability

The buffer in which an antibody is stored plays a critical role in maintaining its stability. Most commercial antibodies are supplied in phosphate-buffered saline (PBS) or Tris-buffered saline (TBS) at pH 7.4–8.0, with added stabilizers.

Cryoprotectants

Glycerol at 50% (v/v) is the most common cryoprotectant for -20°C storage. It prevents freezing by lowering the freezing point and also stabilizes proteins through preferential hydration—glycerol molecules are excluded from the protein surface, stabilizing the native conformation.

Sucrose or trehalose at 5–10% (w/v) can also serve as cryoprotectants, particularly for lyophilized antibodies. These sugars form hydrogen bonds with proteins, replacing water molecules and stabilizing structure during drying and rehydration.

Preservatives

Sodium azide at 0.02–0.05% (w/v) is the most common preservative for antibodies stored at 4°C. It inhibits bacterial and fungal growth by blocking cytochrome oxidase in the electron transport chain. However, sodium azide is toxic and must be handled with appropriate precautions.

Important caveat: Sodium azide can interfere with certain detection methods. For western blotting using horseradish peroxidase (HRP)-conjugated secondary antibodies, sodium azide at concentrations above 0.01% can inhibit HRP activity. If using HRP-based detection, either use azide-free antibody stocks or ensure that the final dilution of antibody in the working solution reduces the azide concentration below inhibitory levels.

Thimerosal at 0.01% (w/v) is an alternative preservative that contains mercury and is effective against a broad spectrum of microorganisms. It is compatible with most detection systems but is toxic and subject to regulatory restrictions in some regions.

Protein Stabilizers

Bovine serum albumin (BSA) at 1–5% (w/v) is often added to antibody stocks as a stabilizer. BSA acts as a carrier protein, reducing non-specific adsorption of antibodies to container surfaces and providing a protective protein matrix. However, BSA can interfere with some applications, particularly if the antibody is used at very high concentrations or if the detection system is sensitive to bovine proteins.

Gelatin or casein can be used as alternatives to BSA for researchers concerned about bovine protein contamination.

Handling Practices: From Receipt to Use

Initial Receipt and Storage

Upon receiving an antibody, immediately inspect the vial for any signs of precipitation, cloudiness, or discoloration. Centrifuge briefly (10,000 × g for 1 minute) to collect any liquid from the cap and to pellet any aggregates that may have formed during shipping.

Record the following information in your laboratory reagent database:

• Antibody name and catalog number
• Lot number and expiration date
• Date received and initial storage location
• Recommended storage conditions from the manufacturer
• Any special handling instructions

Preparing Aliquots

Work in a clean area, preferably a biosafety cabinet or clean bench, to minimize contamination risk. Use sterile pipette tips and tubes. If the antibody is supplied in a buffer containing glycerol, it may be viscous; pipette slowly and allow the solution to equilibrate to room temperature if necessary.

For antibodies that will be stored at -20°C, prepare aliquots in tubes that can withstand freezing. Label each tube with the antibody name, concentration, aliquot volume, date, and your initials.

Thawing and Using Frozen Aliquots

When removing an aliquot from -20°C or -80°C storage, thaw it rapidly by placing the tube in a 37°C water bath for 1–2 minutes, then immediately place on ice. Do not vortex thawed antibodies, as this can cause foaming and denaturation. Instead, mix gently by flicking the tube or inverting it several times.

Centrifuge briefly (10,000 × g for 30 seconds) to collect the solution at the bottom of the tube and to pellet any aggregates that may have formed during freezing. Use the antibody immediately and discard any unused portion. Do not refreeze thawed aliquots.

Working Dilutions

Prepare working dilutions of antibodies fresh for each experiment. Dilute the antibody in the appropriate blocking buffer or antibody dilution buffer (typically PBS or TBS with 1–5% BSA or non-fat dry milk and 0.1% Tween-20). Do not add preservatives to working dilutions, as the buffer components and short incubation time (typically 1 hour to overnight) provide sufficient protection.

Quality Control: Verifying Antibody Activity

Regular quality control testing is essential to ensure that stored antibodies retain their activity. The frequency of testing depends on the antibody's stability and how often it is used.

Functional Testing by Western Blotting

The most direct test of antibody activity is to perform a western blot using a known positive control sample. Compare the signal intensity and specificity with results obtained when the antibody was first received. A significant decrease in signal intensity or an increase in background suggests that the antibody has degraded.

Quantitative approach: Include a dilution series of the positive control lysate on each blot. Compare the signal intensity at each dilution point over time. A 50% reduction in signal at the same dilution indicates substantial activity loss.

Testing for Aggregation

Aggregation can be detected by centrifuging the antibody stock at 14,000 × g for 10 minutes at 4°C. If a visible pellet forms, the antibody has aggregated. Alternatively, measure the absorbance at 280 nm and 340 nm; an increase in A340 relative to A280 indicates light scattering from aggregates.

Testing for Microbial Contamination

Cloudiness or turbidity in the antibody solution is a sign of microbial growth. If contamination is suspected, plate a small volume on LB agar or blood agar and incubate at 37°C for 24–48 hours. Do not use contaminated antibodies, as microbial proteases will degrade the antibody and may introduce artifacts.

Troubleshooting Common Storage Issues

Limitations and Considerations

Antibody-Specific Stability

Not all antibodies are equally stable. Monoclonal antibodies, being homogeneous preparations of a single immunoglobulin species, tend to be more stable than polyclonal antibodies, which contain a mixture of antibodies with different specificities and stabilities. IgM antibodies are generally less stable than IgG antibodies due to their pentameric structure.

Conjugated antibodies (e.g., HRP, alkaline phosphatase, fluorophores) have additional stability considerations. The conjugate itself may be sensitive to freeze-thaw cycles, light, or specific buffer conditions. For example, fluorophore-conjugated antibodies should always be protected from light and stored at 4°C rather than -20°C if the fluorophore is sensitive to freezing.

Manufacturer Variability

Different manufacturers use different formulations and stabilizers. Some antibodies are supplied lyophilized and require reconstitution, while others are supplied as liquid stocks. Always follow the manufacturer's storage recommendations, which are based on stability testing of that specific product.

Reconstitution of Lyophilized Antibodies

For lyophilized antibodies, reconstitute with the recommended volume of sterile water or buffer. Allow the antibody to dissolve completely without vortexing; gentle swirling or periodic inversion over 15–30 minutes is sufficient. After reconstitution, aliquot and store as described above. Some lyophilized antibodies are stable at room temperature for extended periods, but once reconstituted, they should be treated as liquid antibodies.

Documentation and Record Keeping

Maintaining detailed records of antibody storage and handling is essential for reproducibility and troubleshooting. For each antibody, document:

• Receipt information: Date received, condition upon arrival, initial storage location
• Aliquot preparation: Date aliquoted, volume per aliquot, number of aliquots, storage temperature
• Usage log: Date each aliquot was first used, number of times used, any observed changes in performance
• Quality control results: Date of last functional test, signal intensity compared to baseline, any issues noted
• Expiration tracking: Manufacturer's expiration date, date of first use, estimated remaining shelf life based on QC results

A laboratory information management system (LIMS) or simple spreadsheet can be used to track this information. For antibodies used frequently, consider creating a "antibody passport" that accompanies the reagent and is updated each time it is used.

Biosafety Considerations

While antibody storage itself is a BSL-1 level activity, several biosafety considerations apply:

Sodium azide: This preservative is toxic and can form explosive compounds with heavy metals (e.g., copper, lead) in plumbing systems. Dispose of azide-containing solutions according to institutional hazardous waste guidelines. Do not pour azide-containing solutions down the drain.

Thimerosal: Contains mercury and must be handled and disposed of as hazardous waste.

Human-derived antibodies: Antibodies raised against human antigens or purified from human sources should be handled as potentially infectious, even if tested negative for bloodborne pathogens. Follow institutional biosafety guidelines for handling human-derived materials.

Recombinant antibodies: Antibodies produced using recombinant DNA technology may be subject to institutional biosafety committee oversight, particularly if they contain sequences from pathogenic organisms. Consult your institution's biosafety office for guidance.

The Biosafety in Microbiological and Biomedical Laboratories (BMBL) 6th Edition provides authoritative guidance on risk assessment and containment for laboratory reagents [6]. For routine antibody storage and handling, standard microbiological practices (BSL-1) are appropriate, including hand washing after handling, no eating or drinking in the laboratory, and decontamination of work surfaces.

Frequently Asked Questions

1. Can I store antibodies at -20°C without glycerol?

No, this is not recommended. Without a cryoprotectant like glycerol, the aqueous solution will freeze at -20°C, forming ice crystals that can denature the antibody protein. The freeze-thaw cycle itself causes aggregation and activity loss. If you must store antibodies at -20°C without glycerol, use single-use aliquots and thaw only once, but be aware that some activity loss is likely. For optimal stability, always use 50% glycerol or follow the manufacturer's formulation.

2. How long can I keep a working dilution of primary antibody at 4°C?

Working dilutions of primary antibodies in blocking buffer (e.g., 5% BSA or milk in TBST) can typically be stored at 4°C for 1–2 weeks without significant loss of activity. However, this varies by antibody and buffer composition. For best results, prepare fresh working dilutions for each experiment. If you must reuse a working dilution, test it against a positive control to verify activity before using it on experimental samples. Do not add sodium azide to working dilutions if using HRP-based detection.

3. My antibody arrived at room temperature. Is it still usable?

Most commercial antibodies are formulated to withstand short-term temperature excursions during shipping. If the antibody arrived at room temperature but shows no visible precipitation, cloudiness, or discoloration, it is likely still usable. However, you should test it against a known positive control to verify activity. If the antibody was exposed to elevated temperatures for an extended period (e.g., >24 hours at >30°C), contact the manufacturer for guidance. For future orders, request shipment with ice packs or dry ice if available.

4. Can I store antibodies in the refrigerator door rather than the main compartment?

No, the refrigerator door is subject to temperature fluctuations each time the door is opened. These fluctuations can cause condensation and repeated temperature changes that stress the antibody. Store antibodies in the main compartment of the refrigerator, away from the cooling element and door. For -20°C storage, use a dedicated freezer that is not frost-free (frost-free freezers cycle through temperature changes to prevent ice buildup, which can damage antibodies). If only a frost-free freezer is available, store antibodies in the coldest, most stable part of the freezer and minimize door openings.

References and Further Reading

1. Sha H, Duan Q, Lyu D, et al. Follow-up of antibody changes in brucellosis patients in Gansu, China. 2025. PubMed ID: 40304471. https://pubmed.ncbi.nlm.nih.gov/40304471/ — Demonstrates long-term antibody stability monitoring using western blotting in a clinical context.

2. Żołnierkiewicz O, Rogacka D. High Glucose-Induced Alterations in Regucalcin Expression in Podocytes and Their Potential Consequences. 2026. PubMed ID: 41684021. https://pubmed.ncbi.nlm.nih.gov/41684021/ — Uses western blotting to detect protein expression changes, illustrating the importance of antibody quality for reproducible results.

3. Nnyamah C, Boyett J, Wicksteed B, et al. Adipocyte-specific FFA2 deletion leads to increased adipose inflammation and is associated with altered intestinal lipid handling in mice. 2026. PubMed ID: 42083462. https://pubmed.ncbi.nlm.nih.gov/42083462/ — Employs western blotting for protein detection in adipose tissue, highlighting the need for reliable antibody storage.

4. Díaz-Galicia E, Gutu N, Peng Y, et al. Surface Plasmon Resonance (SPR) Workflow for Comparative Analysis of Nanobody Variants Binding to Lysozyme as a Model Ligand. 2026. PubMed ID: 42053294. https://pubmed.ncbi.nlm.nih.gov/42053294/ — Describes nanobody expression and purification, relevant to understanding antibody stability and handling.

5. Li ZH, Asady B, Chang L, et al. Calcium transfer from the ER to other organelles for optimal signaling in Toxoplasma gondii. 2025. PubMed ID: 41222462. https://pubmed.ncbi.nlm.nih.gov/41222462/ — Uses antibodies for protein detection in parasite biology, emphasizing the role of antibody quality in research.

6. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services, 2020. https://www.cdc.gov/labs/bmbl/index.html — Authoritative guidance on biosafety practices for laboratory reagents and materials.

7. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/ — Framework for biosafety oversight of recombinant antibodies and related reagents.

8. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. https://www.ncbi.nlm.nih.gov/books/ — Searchable collection of authoritative methods references for molecular biology techniques.

Related Articles

• How to Store and Handle Restriction Enzymes to Maintain Activity
• Polymerase Storage and Stability: Maintaining Activity for PCR and RT-PCR
• How to Prepare and Store PCR Master Mix for Consistent Results
• How to Store DNA Ladders and Markers for Gel Electrophoresis
• Understanding Enzyme Activity Loss: Causes and Prevention in the Lab
• How to Store and Handle DNA Probes for Hybridization Assays